[Von Willebrand factor, endothelial lesion, and ischemic heart disease]

B Virgós-Señor1, A Nebra-Puertas, M A Suárez-Pinilla

  • 1Servicio de Medicina Intensiva, Hospital Universitario Miguel Servet, Zaragoza, España. beaagus@wanadoo.es

Medicina Intensiva
|April 3, 2008
PubMed

Insights

Patients with ischemic heart disease show elevated von Willebrand factor (FvW) levels, indicating endothelial damage. FvW levels increase post-coronary intervention, suggesting intervention-related endothelial aggression.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Biology

Context:

  • Ischemic heart disease (IHD) is a significant global health concern.
  • Endothelial dysfunction plays a crucial role in IHD pathogenesis.
  • von Willebrand factor (FvW) is a key marker of endothelial activation and damage.

Purpose:

  • To investigate elevated von Willebrand factor (FvW) levels in patients with ischemic heart disease (IHD) compared to healthy controls.
  • To assess the relationship between FvW levels and clinical recurrence or need for coronary intervention.
  • To evaluate changes in FvW levels following coronary intervention procedures.

Summary:

  • This observational study compared FvW levels in 75 IHD patients undergoing coronary intervention with 30 healthy controls.
  • FvW levels were significantly higher in IHD patients (162%±74%) versus controls (95%±33%) (p=0.0001).
  • FvW levels increased significantly post-intervention (162%±74% to 213%±90%, p=0.0001), suggesting intervention-induced endothelial aggression.

Impact:

  • Findings suggest FvW is a sensitive indicator of endothelial alteration in IHD.
  • The study highlights the impact of coronary intervention on endothelial function.
  • Further research may explore FvW as a prognostic marker in IHD management.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...